The topical absorbable hemostats market size has grown strongly in recent years. It will grow from $2.17 billion in 2025 to $2.32 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to increasing orthopedic and cardiothoracic surgeries, adoption of traditional hemostats, rising hospital infrastructure in developed regions, high prevalence of trauma and bleeding disorders, increasing awareness of surgical safety.
The topical absorbable hemostats market size is expected to see strong growth in the next few years. It will grow to $3.03 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to innovation in absorbable hemostatic materials, growth in minimally invasive surgeries, expansion of ambulatory surgical centers, rising geriatric population, demand for faster recovery and reduced hospital stays. Major trends in the forecast period include minimally invasive surgery adoption, surge in surgical procedures, rising focus on patient safety & reduced blood loss, growth in ambulatory surgical centers, development of biocompatible & fast-absorbing hemostats.
The growing number of surgical procedures is expected to drive the expansion of the topical absorbable hemostats market. Surgical procedures involve medically performed operations that include incisions or manipulation of body tissues to diagnose, treat, or improve health conditions. This rise in surgeries is mainly attributed to the increasing aging population, as older adults are more prone to chronic diseases and degenerative conditions that often require surgical intervention. Topical absorbable hemostats are beneficial during surgeries because they quickly control bleeding and do not need to be removed, which helps reduce operation time and lowers the risk of complications. For example, in June 2024, the International Society of Aesthetic Plastic Surgery, a US-based professional organization, reported that aesthetic procedures reached nearly 35 million in 2023, with total surgical and non-surgical procedures increasing by 3.4% to 34.9 million. Thus, the rising volume of surgical procedures is contributing to the growth of the topical absorbable hemostats market.
Key players in the topical absorbable hemostats market are focusing on developing innovative products such as absorbable hemostatic powders to better control bleeding in complex or irregular wound areas. These powders are preferred because they provide rapid bleeding control without needing removal, which reduces infection risks and simplifies post-operative care. For instance, in July 2023, Baxter International, a US-based healthcare company, introduced PERCLOT, an absorbable hemostatic powder. PERCLOT provides surgeons with a comprehensive range of active and passive hemostatic solutions to ensure effective bleeding management. Its specially designed granules absorb moisture almost immediately, forming an adhesive gel that physically seals tissue surfaces. This gel concentrates platelets, red blood cells, and clotting factors like thrombin and fibrinogen, speeding up the body’s natural coagulation process. Reliable control of diverse intraoperative bleeding using PERCLOT can reduce transfusion needs, prevent major complications, and ultimately lower overall treatment costs.
In May 2023, Cousin Surgery, a France-based supplier of implantable medical devices, acquired PlantTec Medical for an undisclosed amount. This acquisition allows Cousin Surgery to broaden its cross-selling opportunities and enhance its research and development capabilities. It also adds a team with specialized expertise in surgical medical devices, strengthening the company’s presence in the German market. PlantTec Medical is a Germany-based manufacturer of topical absorbable hemostats.
Major companies operating in the topical absorbable hemostats market are Johnson And Johnson Services Inc, Baxter International Inc, Integra LifeSciences Holdings Corp, Teleflex Inc, Gelita Medical, Advanced Medical Solutions Group Plc, 3D Matrix Ltd, Advanced Biotech Products Pvt Ltd, Curasan AG, Hemostasis LLC, Medcura Inc, Endomedix Incorporated, BioCer Entwicklungs GmbH, Starch Medical Inc, Arch Therapeutics Inc, Cura Medical BV, Z Medica LLC, Marine Polymer Technologies Inc, Ferrosan Medical Devices, Pfizer Hospital Products, Ethicon Biosurgery.
North America was the largest region in the topical absorbable hemostats market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the topical absorbable hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the topical absorbable hemostats market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the topical absorbable hemostats market by increasing import costs of raw materials and advanced hemostatic products, particularly affecting gelatin-based and collagen-based segments. Regions such as North America and Europe, which rely heavily on imported medical materials, have experienced price fluctuations and supply delays. While the tariffs have created cost pressures, they have also encouraged domestic manufacturing and local sourcing, potentially fostering innovation and development of cost-effective hemostatic solutions in the long term.
The topical absorbable hemostats market research report is one of a series of new reports that provides topical absorbable hemostats market statistics, including topical absorbable hemostats industry global market size, regional shares, competitors with a topical absorbable hemostats market share, detailed topical absorbable hemostats market segments, market trends and opportunities, and any further data you may need to thrive in the topical absorbable hemostats industry. This topical absorbable hemostats market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Topical absorbable hemostats are specialized medical products designed to aid the body’s natural blood clotting during surgical procedures or traumatic bleeding. These agents are applied directly to bleeding areas and are formulated to be gradually broken down and absorbed by the body, eliminating the need for surgical removal.
The primary categories of topical absorbable hemostats include gelatin-based, collagen-based, fibrin-based, cellulose-based, and other types. Gelatin-based hemostats are derived from purified animal gelatin, typically sourced from pigs or cows. They are delivered through various forms such as surgical sprays, pads and gauzes, foams and films, and injectable solutions. These hemostats find applications in orthopedic, cardiothoracic, general, neurological, urological, and gynecological surgeries. Their main users include hospitals, ambulatory surgical centers (ASCs), specialty clinics, and research institutions.
The topical absorbable hemostats market consists of sales of flowable gelatin matrix agents, bioabsorbable composite hemostatic dressings, and dual-component hemostatic kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The topical absorbable hemostats market size is expected to see strong growth in the next few years. It will grow to $3.03 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to innovation in absorbable hemostatic materials, growth in minimally invasive surgeries, expansion of ambulatory surgical centers, rising geriatric population, demand for faster recovery and reduced hospital stays. Major trends in the forecast period include minimally invasive surgery adoption, surge in surgical procedures, rising focus on patient safety & reduced blood loss, growth in ambulatory surgical centers, development of biocompatible & fast-absorbing hemostats.
The growing number of surgical procedures is expected to drive the expansion of the topical absorbable hemostats market. Surgical procedures involve medically performed operations that include incisions or manipulation of body tissues to diagnose, treat, or improve health conditions. This rise in surgeries is mainly attributed to the increasing aging population, as older adults are more prone to chronic diseases and degenerative conditions that often require surgical intervention. Topical absorbable hemostats are beneficial during surgeries because they quickly control bleeding and do not need to be removed, which helps reduce operation time and lowers the risk of complications. For example, in June 2024, the International Society of Aesthetic Plastic Surgery, a US-based professional organization, reported that aesthetic procedures reached nearly 35 million in 2023, with total surgical and non-surgical procedures increasing by 3.4% to 34.9 million. Thus, the rising volume of surgical procedures is contributing to the growth of the topical absorbable hemostats market.
Key players in the topical absorbable hemostats market are focusing on developing innovative products such as absorbable hemostatic powders to better control bleeding in complex or irregular wound areas. These powders are preferred because they provide rapid bleeding control without needing removal, which reduces infection risks and simplifies post-operative care. For instance, in July 2023, Baxter International, a US-based healthcare company, introduced PERCLOT, an absorbable hemostatic powder. PERCLOT provides surgeons with a comprehensive range of active and passive hemostatic solutions to ensure effective bleeding management. Its specially designed granules absorb moisture almost immediately, forming an adhesive gel that physically seals tissue surfaces. This gel concentrates platelets, red blood cells, and clotting factors like thrombin and fibrinogen, speeding up the body’s natural coagulation process. Reliable control of diverse intraoperative bleeding using PERCLOT can reduce transfusion needs, prevent major complications, and ultimately lower overall treatment costs.
In May 2023, Cousin Surgery, a France-based supplier of implantable medical devices, acquired PlantTec Medical for an undisclosed amount. This acquisition allows Cousin Surgery to broaden its cross-selling opportunities and enhance its research and development capabilities. It also adds a team with specialized expertise in surgical medical devices, strengthening the company’s presence in the German market. PlantTec Medical is a Germany-based manufacturer of topical absorbable hemostats.
Major companies operating in the topical absorbable hemostats market are Johnson And Johnson Services Inc, Baxter International Inc, Integra LifeSciences Holdings Corp, Teleflex Inc, Gelita Medical, Advanced Medical Solutions Group Plc, 3D Matrix Ltd, Advanced Biotech Products Pvt Ltd, Curasan AG, Hemostasis LLC, Medcura Inc, Endomedix Incorporated, BioCer Entwicklungs GmbH, Starch Medical Inc, Arch Therapeutics Inc, Cura Medical BV, Z Medica LLC, Marine Polymer Technologies Inc, Ferrosan Medical Devices, Pfizer Hospital Products, Ethicon Biosurgery.
North America was the largest region in the topical absorbable hemostats market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the topical absorbable hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the topical absorbable hemostats market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the topical absorbable hemostats market by increasing import costs of raw materials and advanced hemostatic products, particularly affecting gelatin-based and collagen-based segments. Regions such as North America and Europe, which rely heavily on imported medical materials, have experienced price fluctuations and supply delays. While the tariffs have created cost pressures, they have also encouraged domestic manufacturing and local sourcing, potentially fostering innovation and development of cost-effective hemostatic solutions in the long term.
The topical absorbable hemostats market research report is one of a series of new reports that provides topical absorbable hemostats market statistics, including topical absorbable hemostats industry global market size, regional shares, competitors with a topical absorbable hemostats market share, detailed topical absorbable hemostats market segments, market trends and opportunities, and any further data you may need to thrive in the topical absorbable hemostats industry. This topical absorbable hemostats market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Topical absorbable hemostats are specialized medical products designed to aid the body’s natural blood clotting during surgical procedures or traumatic bleeding. These agents are applied directly to bleeding areas and are formulated to be gradually broken down and absorbed by the body, eliminating the need for surgical removal.
The primary categories of topical absorbable hemostats include gelatin-based, collagen-based, fibrin-based, cellulose-based, and other types. Gelatin-based hemostats are derived from purified animal gelatin, typically sourced from pigs or cows. They are delivered through various forms such as surgical sprays, pads and gauzes, foams and films, and injectable solutions. These hemostats find applications in orthopedic, cardiothoracic, general, neurological, urological, and gynecological surgeries. Their main users include hospitals, ambulatory surgical centers (ASCs), specialty clinics, and research institutions.
The topical absorbable hemostats market consists of sales of flowable gelatin matrix agents, bioabsorbable composite hemostatic dressings, and dual-component hemostatic kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Topical Absorbable Hemostats Market Characteristics
3. Topical Absorbable Hemostats Market Supply Chain Analysis
4. Global Topical Absorbable Hemostats Market Trends and Strategies
5. Topical Absorbable Hemostats Market Analysis of End Use Industries
7. Global Topical Absorbable Hemostats Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Topical Absorbable Hemostats Total Addressable Market (TAM) Analysis for the Market
9. Topical Absorbable Hemostats Market Segmentation
10. Topical Absorbable Hemostats Market Regional and Country Analysis
11. Asia-Pacific Topical Absorbable Hemostats Market
12. China Topical Absorbable Hemostats Market
13. India Topical Absorbable Hemostats Market
14. Japan Topical Absorbable Hemostats Market
15. Australia Topical Absorbable Hemostats Market
16. Indonesia Topical Absorbable Hemostats Market
17. South Korea Topical Absorbable Hemostats Market
18. Taiwan Topical Absorbable Hemostats Market
19. South East Asia Topical Absorbable Hemostats Market
20. Western Europe Topical Absorbable Hemostats Market
21. UK Topical Absorbable Hemostats Market
22. Germany Topical Absorbable Hemostats Market
23. France Topical Absorbable Hemostats Market
24. Italy Topical Absorbable Hemostats Market
25. Spain Topical Absorbable Hemostats Market
26. Eastern Europe Topical Absorbable Hemostats Market
27. Russia Topical Absorbable Hemostats Market
28. North America Topical Absorbable Hemostats Market
29. USA Topical Absorbable Hemostats Market
30. Canada Topical Absorbable Hemostats Market
31. South America Topical Absorbable Hemostats Market
32. Brazil Topical Absorbable Hemostats Market
33. Middle East Topical Absorbable Hemostats Market
34. Africa Topical Absorbable Hemostats Market
36. Topical Absorbable Hemostats Market Competitive Landscape and Company Profiles
37. Topical Absorbable Hemostats Market Other Major and Innovative Companies
40. Topical Absorbable Hemostats Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Topical Absorbable Hemostats Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses topical absorbable hemostats market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for topical absorbable hemostats? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The topical absorbable hemostats market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Gelatin-Based Hemostats; Collagen-Based Hemostats; Fibrin-Based Hemostats; Cellulose-Based Hemostats; Other Types2) By Delivery Method: Surgical Sprays; Pads And Gauzes; Foams And Films; Injectable Solutions
3) By Application: Orthopedic Surgery; Cardiothoracic Surgery; General Surgery; Neurosurgery; Urology; Gynecological Surgery
4) By End-User: Hospitals; Ambulatory Surgical Centers (ASCs); Specialty Clinics; Research Institutions
Subsegments:
1) By Gelatin-Based Hemostats: Gelatin Sponges; Gelatin Powders; Gelatin Films Or Sheets; Flowable Gelatin Matrices2) By Collagen-Based Hemostats: Collagen Sponges; Collagen Powders; Collagen Pads; Collagen Films Or Sheets
3) By Fibrin-Based Hemostats: Fibrin Sealant Sprays; Fibrin Glue; Fibrin Patch Or Film; Combination Fibrin-Based Products
4) By Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC) Pads; Cellulose Meshes; Cellulose Powders; Cellulose Films
5) By Other Types: Chitosan-Based Hemostats; Synthetic Polymer-Based Hemostats; Combination Hemostats; Herbal Or Plant-Derived Hemostats
Companies Mentioned: Johnson And Johnson Services Inc; Baxter International Inc; Integra LifeSciences Holdings Corp; Teleflex Inc; Gelita Medical; Advanced Medical Solutions Group Plc; 3D Matrix Ltd; Advanced Biotech Products Pvt Ltd; Curasan AG; Hemostasis LLC; Medcura Inc; Endomedix Incorporated; BioCer Entwicklungs GmbH; Starch Medical Inc; Arch Therapeutics Inc; Cura Medical BV; Z Medica LLC; Marine Polymer Technologies Inc; Ferrosan Medical Devices; Pfizer Hospital Products; Ethicon Biosurgery
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Topical Absorbable Hemostats market report include:- Johnson And Johnson Services Inc
- Baxter International Inc
- Integra LifeSciences Holdings Corp
- Teleflex Inc
- Gelita Medical
- Advanced Medical Solutions Group Plc
- 3D Matrix Ltd
- Advanced Biotech Products Pvt Ltd
- Curasan AG
- Hemostasis LLC
- Medcura Inc
- Endomedix Incorporated
- BioCer Entwicklungs GmbH
- Starch Medical Inc
- Arch Therapeutics Inc
- Cura Medical BV
- Z Medica LLC
- Marine Polymer Technologies Inc
- Ferrosan Medical Devices
- Pfizer Hospital Products
- Ethicon Biosurgery
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.32 Billion |
| Forecasted Market Value ( USD | $ 3.03 Billion |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
